8-K: Current report
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
8-K: Current report
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director Aliski William
4: Statement of changes in beneficial ownership of securities-Director de Craecker Francoise
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director MCGIRR DAVID W J
4: Statement of changes in beneficial ownership of securities-Director Stewart Murray
4: Statement of changes in beneficial ownership of securities-Director WYZGA MICHAEL S
4: Statement of changes in beneficial ownership of securities-Director Lawton Alison Frances
4: Statement of changes in beneficial ownership of securities-Director Woods Keith
4: Statement of changes in beneficial ownership of securities-Director Bridger Gary
8-K: Current report
8-K: Current report
10-Q: Q1 2024 Earnings Report
8-K: X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
ARS: Annual Report to Security Holders
No Data